URL has been copied successfully!
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- HC Wainwright & Co. analyst Andres Y. Maldonado upgraded Sutro Biopharma, Inc. (NASDAQ:STRO) from Neutral to Buy and raised the price target from $10 to $28. Sutro Biopharma shares closed at $21.33 on Monday. See how other analysts view this stock.
- Daiwa Capital analyst Dennis Ip upgraded JinkoSolar Holding Co., Ltd. (NYSE:JKS) from Sell to Buy and announced a $28.5 price target. JinkoSolar shares …
Please follow us:
This post was originally published here
